Pannu Geraldine
SEC Form 4 insider trading activity
Pannu Geraldine has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including PCSA, RBB, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Pannu Geraldine is listed as Director at Processa Pharmaceuticals, Inc. Inside the rolling window, Pannu Geraldine reported 1 open-market purchase totaling $5K in PCSA and no open-market sales.
Companies traded
Other insiders at PCSA
Insider Buying
$5K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pannu Geraldine made?
Pannu Geraldine has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including PCSA, RBB since 2026.
Which companies does Pannu Geraldine trade?
Pannu Geraldine has filed SEC Form 4 disclosures for 2 companies, including PCSA, RBB.
When was Pannu Geraldine's most recent SEC Form 4 filing?
Pannu Geraldine's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Pannu Geraldine's total buy and sell value in the current window?
Inside the rolling retention window, Pannu Geraldine bought $5K and sold $0 based on SEC Form 4 filings.
What was Pannu Geraldine's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,072 PCSA shares on 2026-03-31, worth $5K, per SEC Form 4 filings.